Allen Andersson Net Worth & Insider Trades
Allen Andersson - Director, Corcept Therapeutics Inc
What is Allen Andersson's Net Worth?
The current estimated net worth of Corcept Therapeutics Inc's Director, Allen Andersson, is estimated to be about $193.34M . Allen Andersson owns about 306,837 units of Corcept Therapeutics Inc common stock. In the last 2 years at Corcept Therapeutics Inc, Allen Andersson has sold an estimated value of $8.14M worth.
What is Allen Andersson's Past Insider Trading?
Allen Andersson's largest purchase order was 2,118,270 units , worth over $5.87M on March 28, 2008. Allen Andersson's largest sale order was 10,914,507 units , worth over $7.51M on February 10, 2009. In total, Allen Andersson has made about 23 transactions over 2 years of their time at Corcept Therapeutics Inc. Allen Andersson usually trades in November, with the busiest year in 2008. The most recent transaction was a sale order of 287,975 units , worth over $201.58K on May 11, 2009.
Allen Andersson
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Allen Andersson's' Mailing Address?
- Mailing address is 62 Sparhawk Lane North Conway NH 20817 NH
Corcept Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Joseph K. Belanoff, M.D., | 2020 | $769,567 | $744,000 | $4,237,643 | $10,892 | $5,762,102 |
| Joseph K. Belanoff, M.D., | 2019 | $707,525 | $745,290 | $3,506,155 | - | $4,958,970 |
| Joseph K. Belanoff, M.D., | 2018 | $679,792 | $477,750 | $5,157,075 | - | $6,314,617 |
| Andreas Grauer, M.D., | 2020 | $454,550 | $219,157 | $1,271,293 | $118,274 | $2,063,274 |
| Andreas Grauer, M.D., | 2019 | $362,267 | $243,720 | $3,115,335 | $78,245 | $3,799,567 |
| Hazel Hunt, Ph.D., | 2020 | $431,873 | $243,000 | $2,084,640 | - | $2,759,513 |
| Sean Maduck, | 2020 | $474,380 | $214,157 | $2,508,404 | - | $3,196,941 |
| Sean Maduck, | 2019 | $456,133 | $308,881 | $1,476,276 | - | $2,241,290 |
| Sean Maduck, | 2018 | $436,667 | $198,000 | $2,171,400 | - | $2,806,067 |
| Charles Robb, | 2020 | $474,380 | $321,236 | $2,118,822 | - | $2,914,438 |
| Charles Robb, | 2019 | $456,133 | $308,881 | $1,845,345 | - | $2,610,359 |
| Charles Robb, | 2018 | $436,667 | $237,600 | $2,171,400 | - | $2,845,667 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm
What are Corcept Therapeutics Inc's Past Insider Trades?
Corcept Therapeutics Inc's most recent insider trade came on December 5, 2022 by Sean Maduck who sold 625 units worth $15.8K . In the last 18 years, insiders at Corcept Therapeutics Inc have sold an estimated value of $197.04M and bought an estimated value of $187.17M worth of shares. Insider trading is most common in February, with the busiest year in 2006. The most active traders at the company are Joseph K Belanoff, Chief Executive Officer, Robert Roe, President and Secretary, and Leonard Baker Jr, Director .
CORCEPT THERAPEUTICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||